- Home
- AAPG vs PENN Comparison
AAPG vs PENN Comparison
Compare AAPG & PENN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AAPG | PENN |
|---|---|---|
| Founded | 2009 | 1972 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Hotels/Resorts |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 1.7B |
| IPO Year | N/A | 1996 |
Fundamental Metrics
Financial Performance| Metric | AAPG | PENN |
|---|---|---|
| Price | $23.88 | $14.79 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 15 |
| Target Price | ★ $48.50 | $20.29 |
| AVG Volume (30 Days) | 1.7K | ★ 4.4M |
| Earning Date | 01-01-0001 | 05-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $6,362,900,000.00 |
| Revenue This Year | N/A | $6.02 |
| Revenue Next Year | $368.64 | $4.31 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $17.56 | $11.65 |
| 52 Week High | $48.45 | $20.61 |
Technical Indicators
Market Signals| Indicator | AAPG | PENN |
|---|---|---|
| Relative Strength Index (RSI) | 47.56 | 55.70 |
| Support Level | $23.06 | $13.87 |
| Resistance Level | $26.01 | $15.21 |
| Average True Range (ATR) | 0.93 | 0.86 |
| MACD | 0.13 | 0.11 |
| Stochastic Oscillator | 62.79 | 74.35 |
Price Performance
Historical ComparisonAbout AAPG Ascentage Pharma Group International American Depository Shares
Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies. The company's geographical segments include the United States and Mainland China.
About PENN PENN Entertainment Inc.
Penn Entertainment's origins date back to its 1972 racetrack opening in Pennsylvania. Today, Penn operates 43 properties across 20 states and 12 brands, including Hollywood Casino and Ameristar. Land-based casinos represented 85% of total sales in 2024; 15% was from the interactive segment, which includes sports, iGaming, and media revenue. The retail portfolio generates mid-30s EBITDAR margins and helps position the company to obtain licenses for the digital wagering markets. Additionally, Penn's media asset, theScore, provides access to sports betting/iGaming technology and clientele, helping it form a leading digital position.